西医治疗痛风药物，由于其不良反应及价格昂贵限制了其临床使用。
Western medicine treatment of gout drug, because of its adverse reactions and the high cost of limiting the clinical use of.
一种药物，C23 H20n2o3s，与苯乙丁氮酮有关系，能促进泌尿器的尿酸的排泄，用于痛风的治疗。
A drug, C23H 20n 2o 3s, related to phenylbutazone, that promotes urinary excretion of uric acid and is used in the treatment of gout.
目的：制备微囊化不可繁殖型尿酸氧化酶工程菌，以期研制一种降低血尿酸的口服药物，用于治疗高尿酸血症及痛风。
Objective: To develop an oral administration to reduce the uric acid in vivo for treatment of hyperuricemia and gout, non-growing E.
结论治疗痛风急性发作主要应根据患者的临床特点以及并发症选择合适的药物，关键是要及早用药。
Conclusions Clinicians should choose appropriate drugs for early treatment of patients with acute gout attack as soon as possible mainly based on clinical features and complications.
药物治疗后，均有不同程度下降，痛风合剂各剂量组下降幅度由低剂量至高剂量依次增加；
The descent range in gouty mixture groups enhanced orderly from low dose to high dose;
泼尼松龙能否作为痛风急性发作期的一线治疗药物？
泼尼松龙能否作为痛风急性发作期的一线治疗药物？
应用推荐